TRV-7019

2025-09-18

SM-164: Advancing IAP Antagonist Strategies in Cancer Res...

2025-09-18

Explore how SM-164, a bivalent Smac mimetic and potent IAP antagonist for cancer therapy, enables rigorous investigation of apoptosis induction in tumor cells and caspase signaling pathways, offering new insights for translational cancer research.

FGFR-IN-1

2025-09-17

GBR 13069 dihydrochloride

2025-09-17

CVT 10216

2025-09-16

SDZ NKT 343

2025-09-16

SWTX-143

2025-09-15

DS89002333

2025-09-13

HPi1

2025-09-12

Anti-CD166 Rabbit Monoclonal Antibody

2025-09-11

Mesoridazine Besylate

2025-09-11

His-tag Protein Purification Kit (Non-Denaturant)

2025-09-10

SR-3677

2025-09-10

EPZ004777 HCl

2025-09-09

Anti-TBP Like 1 Rabbit Monoclonal Antibody

2025-09-08